AACIPM is Asking For Feedback on a Possible Research-Related Advocacy Goal

The International Association for the Study of Pain (IASP) has named 2023 the Global Year for Integrative Pain Care. The goal of IASP’s Global Year advocacy campaign is to, each year, focus on a special aspect of pain and to increase awareness within the pain community and beyond. The aim of this year’s campaign is to increase the awareness of clinicians, scientists, and the public about the use of an integrative pain care approach, which emphasizes non-drug, self-management care.

IASP’s campaign has a number of goals, including: clearly defining “Integrative Pain Care”; examining how various healthcare models can be integrated into a comprehensive pain care plan; and, appraising the quality of evidence for various non-drug approaches to pain care, either provided alone or in combination with other approaches.

AACIPM is connecting with some IASP leaders to discuss the possibilities of more meaningful collaboration throughout the year. We believe that gathering multiple stakeholder organizations together in common interest will have a greater impact than any of us can try to do alone, or with only limited networks.

To that end, please give feedback on what is in the box below!

Collaboration is Key – An Advocacy Opportunity in 2023
The challenges facing our abilities to advance whole person, evidence-based, multimodal, integrative pain management are too big for any one stakeholder or even stakeholder group to solve alone. The Alliance to Advance Comprehensive Integrative Pain Management is working to connect the dots and move the needle!

Calling those with an interest in RESEARCH and COLLABORATION! We would love to hear your thoughts on the issue/need written below that has been identified through initial stakeholder feedback. Do you agree or disagree that this should be addressed? Does it lack important perspective? Other feedback to improve?

Issue/Need – For Your Feedback:

We need more accessible Funding Opportunity Announcements (FOA) that also include promotion of payer/provider partnerships that test translation to clinic and real-world settings when evaluating integrative pain care for all people. Furthermore, related to these funding requests, there should not be mandatory inclusion of basic science/animal studies if basic science would not improve the impact of the study—because basic science isn’t always helpful/needed in this area. 

Innovation, non-traditional partnerships, and payer/provider partnerships have proven successful to address the complexities while advancing access to whole person, integrative pain care for all. To this end, we need more opportunities for building networks, alliances, engagement, and collaboration across stakeholders to promote connections that would normally not occur. Researchers and other stakeholders are often siloed, and connecting the dots is an imperative to promote equitable access to whole person, integrative pain management.

Do you agree or disagree that this should be addressed? Does it lack important perspective? Will this address issues around equity? Other feedback to improve? 

Let us know!